MindRank AI Ltd., a clinical-stage artificial intelligence (AI)-empowered drug discovery company, today announced the ...

At World Sleep 2025, a discussion group examined the emerging role of GLP-1 receptor agonists in obstructive sleep apnea (OSA ...

Placebo-subtracted mean weight loss up to 14.1% after 28 weeks with no plateau Potential for best-in-class tolerability with minimal diarrhea signal, 13% nausea, and 11% vomiting High study and ...

For millions of Americans living with heart failure, getting the right medications at the right doses can be a slow and ...

Cytokinetics (CYTK) announced that additional data related to aficamten were presented in a Late Breaking Clinical Research session at the Heart ...

Multiple sclerosis (MS) often begins in early adulthood, and symptoms may include fatigue, pain, and mood changes. These may not be outwardly visible but can be deeply disabling.[1][1] Clinicians ...

Aficamten is also currently being evaluated in ACACIA-HCM, a Phase 3 clinical trial of aficamten in patients with non-obstructive HCM; CEDAR-HCM, a clinical trial of aficamten in a pediatric ...

When Doug Smith returned home to Strong Township from Sudbury hospital after a heart attack three years ago, the community paramedicine program was there for him.

“The 10-minute rule is a great way to start trying to connect more with a partner you feel distant from,” Lankshear tells ...

This tried-and-true method is one of the best ways to study so you actually retain information—and it's not hard to do. Here's what you need to know.

Background Hospitalisation with acute heart failure (AHF) carries a high risk of death, and those surviving to discharge ...